A total of 381 patients with established (156) or potential (225) sinoatrial dysfunction were included in a 10-year prospective survey to determine the course of the disease and the benefits of pacing. With the exclusion of nine patients who were lost to follow-up, 61 were fitted with pacemakers.
Introduction
Sinoatrial dysfunction (sick-sinus syndrome) accounts for about half of all pacemakers implanted in the USA.' In many instances incapacitating symptoms are the indication for treatment, and the response may be dramatic and rewarding. Increasingly, however, unsuspected sinoatrial dysfunction is being discovered, particularly by ambulant 24-hour tape monitoring. ' In such cases pacemaker implantation may be recommended for fear that a prolonged period of sinus arrest or other arrhythmias will prove fatal. In heart block the mortality of patients without pacemakers is high,3 but the course of sinoatrial disease is largely unknown.' 4 5Nevertheless, a poor prognosis has been Cardiac Department, Royal Devon suggested irrespective of elective pacing,6 7 8 whereas Gann et al,9 in a retrospective survey, found the outlook to be good.
We have conducted a 10-year prospective survey to assess survival in paced and unpaced patients with sinoatrial disorder.
Patients and methods
Patients with bradycardia associated with slow sinus and atrial rates were recruited from the Devon Heart Block and Bradycardia Survey' 0" during 1968-76. We studied 381 patients, all of whom had persistent sinus bradycardia (atrial rate under 56 beats/minute) in the absence of recent myocardial infarction or cardioactive drug treatment -for example, digitalis and beta-blocking agents. They were divided into two groups.
Patients in group 1 were considered to have established chronic sinoatrial disorder as defined by bradycardia with one or more of the following abnormalities: (1) periods of sinus arrest or sinoatrial block, in which atrial activity stopped for two seconds or more, recorded by routine electrocardiography; (2) 
Results
The mean age of patients in group 1 (61-7 years) was 3-5 years greater than that in group 2 (58 2 years), but this was not significant (p<01, Kolmogorov-Smirnov test). The mean age of those fitted with pacemakers was 63-0 years. Survival in the two groups wag similar, the five-year survival being about 80% (figure 1). The survival curves of both groups were also similar to that estimated for a normal population of similar age and sex distribution. A---A) and estimated survival curve for normal population of similar age and sex distribution (0-0). Figure 2 shows the survival curves for unpaced and paced patients. The curves for the paced patients were calculated by taking survival from the date of implantation or from the date of admission to the survey. The results of the first method showed that these patients fared marginally worse than the unpaced patients, though this difference was not significant (p < 0 07, log-rank test). There was no appreciable difference between the results for both groups when the second method of calculation was used. 
Discussion
In this study the overall survival rate of patients with established and potential sinoatrial disorder was apparently closely similar to that of the normal population. The probability of missing an 8% difference in survival at three years with the number of patients studied was no more than 10%. The effects of other factors such as myocardial infarction, cardiac failure, and Stokes-Adams attacks were small, and because of age differences interpretation was difficult. Larger studies are therefore needed.
Pacemaker implantation for sinoatrial disorder does not appreciably reduce mortality, even in patients with symptoms. The long history in some forms of sinoatrial dysfunction is well known,16-18 and in our series the follow-up period may have been too short to confirm an increased mortality in patients without pacemakers. Some of the patients had been followed up for 10 years but most were followed up for only five; hence in [10] [11] [12] [13] [14] [15] comparing the response to a standard meal in 34 such patients and 34 controls. To limit the study as far as possible to patients with cholesterol gall stones we included only those with radiolucent stones, since 80% of such stones contain over 70% cholesterol. 4 We were careful to match the patients and controls in pairs for age, sex, obesity, and race because the prevalence of cholesterol gall stones is related to these factors5 6 and gallbladder emptying is affected by age and sex.'
Patients and methods
We studied 34 patients with radiolucent gall stones in a gall bladder that opacified on oral cholecystography. Patients with calcified gall stones and those whose gall stones occupied over half of the gallbladder volume were excluded. We also studied 34 control subjects with dyspeptic symptoms and an unequivocally normal cholecystogram. They were matched in pairs with the patients with gall stones for age (within 10 years), height (10 cm), body weight (10 kg), race, and sex. Ten of the pairs were men and 24 women. The mean age of the patients was 52 years and of the controls 53 years; the corresponding mean weights were 72 kg and 68 kg, and the corresponding mean heights 167 cm and 164 cm. Six patients and six controls were over 1200% of their ideal body weight. Written informed consent was obtained from all subjects before they entered the study.
We assessed gall-bladder emptying by means of carefully standardised oral cholecystography. The subject was supine, and angulation over the x-ray film was adjusted by means of a wooden wedge to give an angle of 45°. The x-ray tube was adjusted to a distance of 100 cm from the plate. In premenopausal women cholecystography was carried out within 10 days after the onset of the menstrual cycle, thus eliminating differences in emptying during different phases of the menstrual cycle.8 X-ray films were taken in the fasting state and 15, 30, and 60 minutes after a standard liquid test meal (Lundh), a pilot study having shown that maximum emptying always occurred within the first hour after the meal. The gall bladder was outlined on tracing paper. Area was measured by means of a grid system, and volume was calculated by the method described and validated by Silva.9 Both measurements were made by someone unaware of the diagnosis. Statistical analysis was carried out by using the Wilcoxon signed-rank test for paired samples.
